The Food and Drug Administration recently approved India-based Glenmark Pharmaceutical's lidocaine ointment.
Supply Chain
The high price of EpiPens introduced a nationwide discussion on Mylan's pricing practices and the overall state of the drug industry. However, not all parts of the discussion have been accurate.
Procured Health recently hosted a panel to discuss effective physician engagement strategies to produce a more efficient supply chain that improves costs, quality and clinical outcomes.
While numerous companies attempted to set foot in the epinephrine auto-injection market, none were able to significantly impact Canonsburg, Pa.-based Mylan's control of the market. This dominance allowed Mylan to make major price hikes to its EpiPens, increasing the price by…
In June 2005, a physician colleague and I published an article in The Physician Executive magazine entitled: "ABCs of TJR – Physician Involvement Helps build a Profitable Program."
Advertisement
U.S. Senate Judiciary Chairman Chuck Grassley (R-Iowa) said Mylan's seven-page letter addressing the company's nearly 550 percent price hike for EpiPens — which administer life-saving shots of epinephrine to stop allergic reactions — lacked details on how it decided to…
The Food and Drug Administration is proposing to crack down on clinics that offer expensive stem cell therapies for various conditions such as autism, multiple sclerosis and erectile dysfunction, reports STAT.
Are today's hospitals underinvesting in their ability to transform data into actionable information?
Insight from the top performers on Gartner's Healthcare Supply Chain 25.
The controversy surrounding the cost of EpiPen's did not stop Fortune from including Mylan CEO Heather Bresch on its "Most Powerful Women" list for 2016.
The Food and Drug Administration will conduct a "thorough investigation" of allegations that St. Jude Medical's heart devices have cybersecurity vulnerabilities, according to Reuters.